Invitrogen Posts Fourth-Quarter Loss On Charges

Invitrogen , which provides tools and cultures used in genetic research and drug production, reported a fourth-quarter loss on Tuesday due to a large goodwill impairment charge and other one-time charges.

The company, of Carlsbad, Calif., posted a net loss of $100.2 million, or $2.08 a share, compared with a profit of $49.6 million, or 87 cents a share, a year ago.

Excluding 13 cents a share for stock options expenses and other items, Invitrogen earned $1.01 per share. Analysts on average expected 73 cents a share, according to a Thomson Financial poll.